JNJ stock: buy or sell
Jan 18th, 2021
JNJ stock brief
- After hitting all-time highs last Thursday, Johnson & Johnson closed last Friday at $160.30 just moving a -0.22%
- Johnson & Johnson is presenting its earnings report on Wednesday
- Johnson & Johnson researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
Should I buy Johnson & Johnson stock?
All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $JNJ stock a buy?
Currently, Johnson & Johnson stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for $JNJ in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems
Should I sell Johnson & Johnson stock?
Knowing when to sell a stock is even harder than knowing when to buy it. Trading strategies allow us to avoid impulsive decisions based on our personal sentiments or the buzz that surrounds the market. When selling, as well as buying, our strategies are very easy to follow and are only applicable for selling shares in your porfolio, not for selling short $JNJ stock
As a rule of thumb, you should never mantain an open trade that produces losses greater than those expected upon purchase. The timing to sell your stock must always be dictated by the stop-loss (automatic or manual)
Is it time to sell Johnson & Johnson stock?
In the current situation of Johnson & Johnson there is not any eligible sell setup, so Johnson & Johnson stock holders with operations in green can keep their positions
Johnson & Johnson ratings
In the last month we couldn't find any rating for Johnson & Johnson
Johnson & Johnson stock analysis
$JNJ at All-time Highs
Last Thursday, Johnson & Johnson reached all-time highs (ATH) again at $161.95. Stock rallied fast in the last 2 weeks, cracking new all-time highs 5 times
Supports and resistances
Price is at highs and there are not upper resistance levels.
The current supports are:
Since the price surpassed the upper band on January 7, the price sliced by 0.45%. The price is trading very close to the upper Bollinger band, indicating some level of overbought in recent sessions. This is not a sell point, as price can trade in these levels for many days and weeks
Relative strength index
The RSI dropped below the overbought level of 70 on January 11 after just crossing to the overbough zone for 1 day (weak signal). The RSI value last Friday was 66.24. Johnson & Johnson shares slightly changed a 0.16% since that level was lost
Johnson & Johnson stock price history
Johnson & Johnson started trading priced at an adjusted price1 of $0.00 on Jan 1962. Since then, JNJ stock has risen by -, with an average of 0.00% per year. If you had invested $1,000USD in Johnson & Johnson stock at that time, it would have a value of $inf today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Johnson & Johnson stock
How much a stock will be priced tomorrow or next week is quite unpredictable. However, many stock price predictions are posted every day by banks, financial institutions and independent analysts.
The following table shows the price forecasts released by financial institutions over the last 30 days. Again, these forecasts are not direct recommendations for individual traders and must not be trusted blindly.
We don't have any target price posted in the previous month for Johnson & Johnson.
Earnings and financials
JNJ ($JNJ) is posting quarterly earnings report on Wednesday. Forecasted for this quarter is $1.83, compared to $2.20 that was reported for Q3.
If you are a shareholder of Johnson & Johnson stock, don't forget to double check your stop-loss, as financial report release day has higher than usual volatility. Johnson & Johnson's website probably has further details.
Johnson & Johnson ($JNJ) hosted the earnings call and released the report last October. JNJ presented earnings of $2.20 per share on revenue of $21.1 billion. The market estimate was $1.98 per share on revenue of $20.2 billion.This compares to Earnings of $2.12 per share a year ago, so reported EPS means an improvement of 3.77%.
Johnson & Johnson performance
|Johnson & Johnson ($JNJ)||6.70%||9.40%||8.20%|
Please read:The viewpoints published in this article are personal and should not be followed as recommendations for you to buy or sell shares. The author of this paper does not have any knowledge of the specific positions of the reader, his or her own financial statements or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Opinions are published for educative reasons only
|Friday, January 15th, 2021|
|Day range||$159.11 - $161.41|
|Average true range||$2.88|
|50d mov avg||$150.67|
|100d mov avg||$148.29|
|200d mov avg||$146.24|
|Earnings date||January 20th, 2021|